• Careers
  • Contact
Crescendo
  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisers
    • Investors
  • Humabody®
    • Overview
    • Transgenic VH Platform
    • Humabody® Therapeutics
  • Pipeline
    • Overview
    • Our Proprietary Pipeline
    • Our Assets for Partnering
    • Collaboration Programmes
  • Partnering
  • News & Media
    • PR & News
    • In the Press
    • Press Kit
    • Videos
    • Posters & Publications
  • Events
  • Menu

CB307 A novel T cell costimulatory Humabody® VH therapeutic for PSMA-positive tumors

12 April 2019/in Posters & Publications /by fr00fRoU

CB307 A novel T cell costimulatory Humabody® VH therapeutic for PSMA-positive tumors (PEGS 2019 poster)

View Poster

/wp-content/uploads/2016/02/logo_crescendo.png 0 0 fr00fRoU /wp-content/uploads/2016/02/logo_crescendo.png fr00fRoU2019-04-12 11:56:382019-09-04 12:25:53CB307 A novel T cell costimulatory Humabody® VH therapeutic for PSMA-positive tumors

Recent Posts

  • Crescendo Biologics Reaches Fifth Milestone in its Strategic Collaboration with Takeda
  • Crescendo Biologics Reaches Fifth Milestone in its Strategic Collaboration with Takeda
  • Crescendo Biologics to collaborate with world-leading oncology groups at the University of Oxford and the University of Surrey
  • Crescendo Biologics to collaborate with world-leading oncology groups at the University of Oxford and the University of Surrey
  • Crescendo Biologics strengthens leadership team with appointment of ex-GSK Stewart Kay, as Chief Business Officer

Archives

  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • January 2019
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • February 2017
  • January 2017
  • November 2016
  • October 2016
  • September 2016
  • April 2016
  • February 2016
  • November 2015
  • October 2015
  • May 2015
  • March 2015
  • January 2015
  • December 2014
  • October 2014
  • April 2014
  • March 2014
  • December 2013
  • January 2013
  • October 2012
  • August 2012
  • June 2011
  • April 2011
  • January 2011
  • September 2010
  • January 2010
  • October 2009

Humabody® is a registered trademark of Crescendo Biologics Ltd.

Meditrina Building 260, Babraham Research Campus, Cambridge, CB22 3AT
© Crescendo Biologics  ·  privacy policy  · website by Instinctif Partners
Theodora Harold to be appointed new CEO at Crescendo Biologics Crescendo broadens patent protection in US on VH-producing lambda chain KO ...
Scroll to top